Header Logo

David A Smelson PsyD

TitleProfessor
InstitutionUMass Chan Medical School
DepartmentPsychiatry
AddressUMass Chan Medical School
365 Plantation Street Biotech One
Worcester MA 01605
Phone508-856-3768
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentMedicine

    InstitutionT.H. Chan School of Medicine
    DepartmentPsychiatry

    InstitutionMorningside Graduate School of Biomedical Sciences
    DepartmentMillennium MD/PhD Program


    Collapse Biography 
    Collapse education and training
    Illinois School of Professional Psychology at Argosy University, Chicago, IL, United StatesBSProfessional Studies
    Upsala College, East Orange, NJ, United StatesMSPsychology
    Illinois School of Professional Psychology at Argosy University, Chicago, IL, United StatesPSYDPsychology

    Collapse Overview 
    Collapse overview

    Dr. David Smelson is a Tenured Professor of Psychiatry at the University of Massachusetts Medical School, and former Vice Chair of Clinical Research, a position he held from 2008-2018. He currently directs the University of Massachusetts Medical School, Center of Excellence in Addictions. He has been consecutively funded federally for the past 25 years by NIH (NIDA, NIAAA, NCCIH), VA, BJA and SAMHSA. His work focuses on studying and implementing treatments for addiction and co-occurring mental health and substance use.

    Examples of funding include:

    NIMH 1R01MH128904-01 (Smelson, Gonzalez, Li)  (Co-PI's)                                                                                                             Title: Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders

    THis project will test MISSION as a whole or its parts in addition to Medication for Opioid use Disorder (MOUD) and the cost implications for opioid addiction.

    Costs: $12,321,934

    Role: Co-Principal Investigator

    NIH/NIAAA R01AA028240-01A (Epstein, Smelson, Sherman) (Co-PI's)  

    Title: A Female-Specific Cognitive Behavioral Therapy Group for Alcohol Use Disorder in VA Primary Care Settings

    This randomized clinical trial will test a female-Veteran-centric adapted CBT group therapy for AUD and other health behaviors located in VA Primary Care setting.

    Costs: $3,638,940

    Role: Co-Principal Investigator

    NIH/NIDA R41DA044030-01A1 David Smelson (PI) 
    Title: MISSION-U: A Multimedia Training Tool for Treating Individuals with Co-occurring Mental Health and Substance Use Disorders
    This study involves the partnering with a small business to commercialize continuing education for the MISSION Model and creating a continuing education platform for MISSION.
    Costs: $243,000, direct & indirect costs
    Role: Principal Investigator 

    NIH/NIDA R42 AA026751-2 David Smelson (PI) 
    Title: MISSION-U: A Multimedia Training Tool for Treating Individuals with Co-occurring Mental Health and Substance Use Disorders
    This is a phase 2 study in partnership between UMASS Medical School and Praxis to commercialize a continuing education e-learning program to train treatment providers on the MISSION Model.
    Costs: $1,499,913.00, direct & indirect costs
    Role: Principal Investigator

    NIDA K23 Award Stephanie Carreiro (PI) 
    Title: iTransform: Wearable Biosensors to Detect the Evolution of Opioid Tolerance in Opioid Naïve Individuals
    This project utilizes machine learning approaches to evaluate opioid use and the evolution of tolerance in opioid naive individuals as measured by a wearable biosensor.
    Costs: $800,000.00, direct & indirect costs
    Role: Mentor (donated)

    SAMHSA CSAT 1H79TI080430 David Smelson (PI) 
    Title: Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking-Western Massachusetts (MISSION-West)
    The goals of this project are to implement and evaluate the MISSION model for ending chronic homelessness in Springfield Metro Area.
    Costs: $2,135,454.00, direct & indirect costs
    Role: Principal Investigator

    BRIDGE QUERI Center of Excellence
    Title: The BRIDGE QUERI
    The BRIDGE QUERI includes a series of center cores and four projects that focuses on interventions for vulnerable populations of Veterans, including those experiencing homelessness, those with HIV and Hepatitis C and those exiting incarceration. The primary contribution of these projects and the center cores will be to refine service delivery models to address the health care and other service needs of these underrepresented populations.
    Costs: $3,975,000.00, direct & indirect costs.
    Role: Co-Principal Investigator 

     VA HSR&D Investigator Initiated Research Daniel Blonigen, David Smelson (Co-PIs) 
    Title: Improving Treatment Engagement and Outcomes among Justice-involved Veterans
    This project will be a multisite RCT to test the effectiveness of Moral Reconation Therapy to reduce risk for criminal recidivism and improve health-related outcomes among justice-involved Veterans.
    Costs: $1,362,265.00, direct costs



    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kim B, Petrakis BA, McInnes DK, Gifford AL, Sliwinski SK, Smelson DA. Applying after action review to examine residential treatment programs' responses to COVID-19. Int J Health Plann Manage. 2022 Apr 13. PMID: 35419883.
      Citations:    Fields:    
    2. Blonigen DM, Cucciare MA, Byrne T, Shaffer PM, Giordano B, Smith JS, Timko C, Rosenthal J, Smelson D. A randomized controlled trial of moral reconation therapy to reduce risk for criminal recidivism among justice-involved adults in mental health residential treatment. J Consult Clin Psychol. 2022 Apr 11. PMID: 35404638.
      Citations:    Fields:    
    3. Smelson DA, Yakovchenko V, Byrne T, McCullough MB, Smith JL, Bruzios KE, Gabrielian S. Testing implementation facilitation for uptake of an evidence-based psychosocial intervention in VA homeless programs: A hybrid type III trial. PLoS One. 2022; 17(3):e0265396. PMID: 35298514.
      Citations:    Fields:    
    4. Blonigen DM, Smith JS, Javier S, Cucciare MA, Timko C, Nevedal AL, Filice N, Rosenthal J, Smelson D. Implementation Potential of Moral Reconation Therapy for Criminal Recidivism in Mental Health Residential Programs. Psychiatr Serv. 2022 Jan 26; appips202100089. PMID: 35080418.
      Citations:    Fields:    
    5. Leach R, Carreiro S, Shaffer PM, Gaba A, Smelson D. Digital Health Interventions for Mental Health, Substance Use, and Co-occurring Disorders in the Criminal Justice Population: A Scoping Review. Front Psychiatry. 2021; 12:794785. PMID: 35126204.
      Citations:    
    6. Mitra A, Ahsan H, Li W, Liu W, Kerns RD, Tsai J, Becker W, Smelson DA, Yu H. Risk Factors Associated With Nonfatal Opioid Overdose Leading to Intensive Care Unit Admission: A Cross-sectional Study. JMIR Med Inform. 2021 Nov 08; 9(11):e32851. PMID: 34747714.
      Citations:    
    7. Taylor EN, Timko C, Binswanger IA, Harris AHS, Stimmel M, Smelson D, Finlay AK. A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration. Subst Abus. 2022; 43(1):556-563. PMID: 34586978.
      Citations:    Fields:    Translation:Humans
    8. Macia KS, Blonigen DM, Shaffer PM, Cloitre M, Smelson DA. Trauma-related differences in socio-emotional functioning predict housing and employment outcomes in homeless veterans. Soc Sci Med. 2021 07; 281:114096. PMID: 34126293.
      Citations:    Fields:    Translation:Humans
    9. Holzhauer CG, Epstein EE, Smelson DA, Mattocks K. Targeting women veteran's stress-induced drinking with cognitive reappraisal: Mechanisms and moderators of change. J Subst Abuse Treat. 2021 11; 130:108408. PMID: 34118700.
      Citations:    Fields:    Translation:Humans
    10. Jasuja GK, Bettano A, Smelson D, Bernson D, Rose AJ, Byrne T, Berlowitz DR, McCullough MB, Miller DR. Homelessness and Veteran Status in Relation to Nonfatal and Fatal Opioid Overdose in Massachusetts. Med Care. 2021 04 01; 59(Suppl 2):S165-S169. PMID: 33710090.
      Citations: 1     Fields:    Translation:Humans
    11. Finlay AK, Harris AHS, Timko C, Yu M, Smelson D, Stimmel M, Binswanger IA. Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration. J Addict Med. 2021 04 01; 15(2):143-149. PMID: 32826617.
      Citations: 5     Fields:    Translation:Humans
    12. Morse E, Binswanger IA, Taylor E, Gray C, Stimmel M, Timko C, Harris AHS, Smelson D, Finlay AK. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. J Subst Abuse Treat. 2021 10; 129:108353. PMID: 34080564.
      Citations:    Fields:    Translation:Humans
    13. Pinals DA, Gaba A, Shaffer PM, Andre MA, Smelson DA. Risk-need-responsivity and its application in behavioral health settings: A feasibility study of a treatment planning support tool. Behav Sci Law. 2021 Feb; 39(1):44-64. PMID: 33569766.
      Citations:    Fields:    Translation:Humans
    14. Blonigen DM, Shaffer PM, Smith JS, Cucciare MA, Timko C, Smelson D, Blue-Howells J, Clark S, Rosenthal J. Recidivism Treatment for Justice-Involved Veterans: Evaluating Adoption and Sustainment of Moral Reconation Therapy in the US Veterans Health Administration. Adm Policy Ment Health. 2021 11; 48(6):992-1005. PMID: 33515346.
      Citations: 1     Fields:    Translation:Humans
    15. Boyer EW, Levy S, Smelson D, Vargas S, Casey A. The Clinical Assessment of Vaping Exposure. J Addict Med. 2020 12; 14(6):446-450. PMID: 32032211.
      Citations:    Fields:    Translation:Humans
    16. Byrne T, Baggett T, Land T, Bernson D, Hood ME, Kennedy-Perez C, Monterrey R, Smelson D, Dones M, Bharel M. A classification model of homelessness using integrated administrative data: Implications for targeting interventions to improve the housing status, health and well-being of a highly vulnerable population. PLoS One. 2020; 15(8):e0237905. PMID: 32817717.
      Citations: 1     Fields:    Translation:Humans
    17. Timko C, Tsai J, Taylor E, Smelson D, Blonigen D, Nash A, Finlay A. Clients of VA-Housed Legal Clinics: Legal and Psychosocial Needs When Seeking Services and Two Months Later. J Veterans Stud. 2020 Jul 29; 6(1):239-249. PMID: 34466762.
      Citations:    
    18. Finlay AK, Morse E, Stimmel M, Taylor E, Timko C, Harris AHS, Smelson D, Yu M, Blue-Howells J, Binswanger IA. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study. J Gen Intern Med. 2020 09; 35(9):2529-2536. PMID: 32583337.
      Citations: 4     Fields:    Translation:Humans
    19. Ellison ML, Schutt RK, Yuan LH, Mitchell-Miland C, Glickman ME, McCarthy S, Smelson D, Schultz MR, Chinman M. Impact of Peer Specialist Services on Residential Stability and Behavioral Health Status Among Formerly Homeless Veterans With Cooccurring Mental Health and Substance Use Conditions. Med Care. 2020 04; 58(4):307-313. PMID: 31914105.
      Citations: 3     Fields:    Translation:Humans
    20. Rumbut J, Fang H, Wang H, Carreiro S, Smelson D, Chapman B, Boyer E. Harmonizing Wearable Biosensor Data Streams to Test Polysubstance Detection. Int Conf Comput Netw Commun. 2020 Feb; 2020:445-449. PMID: 33732746.
      Citations:    
    21. Carreiro S, Chintha KK, Shrestha S, Chapman B, Smelson D, Indic P. Wearable sensor-based detection of stress and craving in patients during treatment for substance use disorder: A mixed methods pilot study. Drug Alcohol Depend. 2020 04 01; 209:107929. PMID: 32193048.
      Citations: 7     Fields:    Translation:Humans
    22. Blonigen DM, Macia KS, Smelson D, Timko C. Criminal recidivism among justice-involved veterans following substance use disorder residential treatment. Addict Behav. 2020 07; 106:106357. PMID: 32120199.
      Citations: 1     Fields:    Translation:Humans
    23. Smelson DA, Gaba A, Pressman K, Clary KM, Shaffer PM, Pinals DA. Embedding a Co-occurring Disorders Rehabilitation Intervention in Veterans Courts: A Pilot Study with Male Veterans. Community Ment Health J. 2020 07; 56(5):970-977. PMID: 32006293.
      Citations:    Fields:    Translation:Humans
    24. Timko C, Taylor E, Nash A, Blonigen D, Smelson D, Tsai J, Finlay AK. National Survey of Legal Clinics Housed by the Department of Veterans Affairs to Inform Partnerships with Health and Community Services. J Health Care Poor Underserved. 2020; 31(3):1440-1456. PMID: 33416704.
      Citations: 1     Fields:    Translation:Humans
    25. Midboe AM, Byrne T, Smelson D, Jasuja G, McInnes K, Troszak LK. The Opioid Epidemic In Veterans Who Were Homeless Or Unstably Housed. Health Aff (Millwood). 2019 08; 38(8):1289-1297. PMID: 31381401.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    26. Pinals DA, Gaba A, Clary KM, Barber J, Reiss J, Smelson D. Implementation of MISSION-Criminal Justice in a Treatment Court: Preliminary Outcomes Among Individuals With Co-occurring Disorders. Psychiatr Serv. 2019 11 01; 70(11):1044-1048. PMID: 31337322.
      Citations:    Fields:    Translation:Humans
    27. Corrigan PW, Qin S, Davidson L, Schomerus G, Shuman V, Smelson D. Public Perceptions of Recovery Prospects and Peer Style (Support and Confrontation) in Services for Serious Mental Illness Versus Substance Use Disorder. J Dual Diagn. 2019 Oct-Dec; 15(4):226-232. PMID: 31311451.
      Citations: 1     Fields:    Translation:Humans
    28. Corrigan PW, Qin S, Davidson L, Schomerus G, Shuman V, Smelson D. How does the public understand recovery from severe mental illness versus substance use disorder? Psychiatr Rehabil J. 2019 Dec; 42(4):341-349. PMID: 31246074.
      Citations:    Fields:    Translation:Humans
    29. Holzhauer CG, Byrne T, Simmons MM, Smelson D, Epstein EE. Profiles of Clinical Need Among Homeless Individuals with Dual Diagnoses. Community Ment Health J. 2019 11; 55(8):1305-1312. PMID: 31236735.
      Citations:    Fields:    Translation:Humans
    30. Hanna J, Kubiak S, Pasman E, Gaba A, Andre M, Smelson D, Pinals DA. Evaluating the implementation of a prisoner re-entry initiative for individuals with opioid use and mental health disorders: Application of the consolidated framework for implementation research in a cross-system initiative. J Subst Abuse Treat. 2020 01; 108:104-114. PMID: 31285078.
      Citations: 2     Fields:    Translation:Humans
    31. Corrigan PW, Larson JE, Smelson D, Andra M. Recovery, peer support and confrontation in services for people with mental illness and/or substance use disorder. Br J Psychiatry. 2019 03; 214(3):130-132. PMID: 30774058.
      Citations: 4     Fields:    Translation:Humans
    32. Jabeen S, Clough ECS, Thomlinson AM, Chadwick SL, Ferguson MWJ, Shah M. Partial thickness wound: Does mechanism of injury influence healing? Burns. 2019 05; 45(3):531-542. PMID: 33864989.
      Citations:    Fields:    Translation:Humans
    33. Jabeen S, Clough ECS, Thomlinson AM, Chadwick SL, Ferguson MWJ, Shah M. Partial thickness wound: Does mechanism of injury influence healing? Burns. 2019 05; 45(3):531-542. PMID: 22311668.
      Citations: 26     Fields:    Translation:Humans
    34. Jabeen S, Clough ECS, Thomlinson AM, Chadwick SL, Ferguson MWJ, Shah M. Partial thickness wound: Does mechanism of injury influence healing? Burns. 2019 05; 45(3):531-542. PMID: 9828997.
      Citations: 2     Fields:    Translation:HumansCells
    35. Jabeen S, Clough ECS, Thomlinson AM, Chadwick SL, Ferguson MWJ, Shah M. Partial thickness wound: Does mechanism of injury influence healing? Burns. 2019 05; 45(3):531-542. PMID: 9161774.
      Citations:    Fields:    Translation:Humans
    36. Smelson DA, Perez CK, Farquhar I, Byrne T, Colegrove A. Permanent Supportive Housing and Specialized Co-Occurring Disorders Wraparound Services for Homeless Individuals. J Dual Diagn. 2018 Oct-Dec; 14(4):247-256. PMID: 30609903.
      Citations: 1     Fields:    Translation:Humans
    37. Jasuja GK, Ameli O, Miller DR, Land T, Bernson D, Rose AJ, Berlowitz DR, Smelson DA. Overdose risk for veterans receiving opioids from multiple sources. Am J Manag Care. 2018 11; 24(11):536-540. PMID: 30452210.
      Citations: 3     Fields:    Translation:Humans
    38. Finlay AK, Binswanger IA, Timko C, Smelson D, Stimmel MA, Yu M, Bowe T, Harris AHS. Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science. J Subst Abuse Treat. 2018 12; 95:43-47. PMID: 30352669.
      Citations: 5     Fields:    Translation:Humans
    39. Rogers ES, Gillespie C, Smelson D, Sherman SE. A Qualitative Evaluation of Mental Health Clinic Staff Perceptions of Barriers and Facilitators to Treating Tobacco Use. Nicotine Tob Res. 2018 09 04; 20(10):1223-1230. PMID: 29059344.
      Citations: 4     Fields:    Translation:Humans
    40. Smelson DA, Chinman M, Hannah G, Byrne T, McCarthy S. An evidence-based co-occurring disorder intervention in VA homeless programs: outcomes from a hybrid III trial. BMC Health Serv Res. 2018 May 05; 18(1):332. PMID: 29728148.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    41. McIlvane WJ, Kledaras JB, Gerard CJ, Wilde L, Smelson D. Algorithmic analysis of relational learning processes in instructional technology: Some implications for basic, translational, and applied research. Behav Processes. 2018 Jul; 152:18-25. PMID: 29544867.
      Citations:    Fields:    Translation:Humans
    42. Blonigen DM, Cucciare MA, Timko C, Smith JS, Harnish A, Kemp L, Rosenthal J, Smelson D. Study protocol: a hybrid effectiveness-implementation trial of Moral Reconation Therapy in the US Veterans Health Administration. BMC Health Serv Res. 2018 03 07; 18(1):164. PMID: 29514649.
      Citations: 4     Fields:    Translation:Humans
    43. Smelson D, Farquhar I, Fisher W, Pressman K, Pinals DA, Samek B, Duffy MK, Sawh L. Integrating a Co-occurring Disorders Intervention in Drug Courts: An Open Pilot Trial. Community Ment Health J. 2019 02; 55(2):222-231. PMID: 29516336.
      Citations: 4     Fields:    Translation:Humans
    44. Carreiro S, Chai PR, Carey J, Lai J, Smelson D, Boyer EW. mHealth for the Detection and Intervention in Adolescent and Young Adult Substance Use Disorder. Curr Addict Rep. 2018 Jun; 5(2):110-119. PMID: 30148037.
      Citations:    
    45. DiGirolamo GJ, Gonzalez G, Smelson D, Guevremont N, Andre MI, Patnaik PO, Zaniewski ZR. Increased Depression and Anxiety Symptoms are Associated with More Breakdowns in Cognitive Control to Cocaine Cues in Veterans with Cocaine Use Disorder. J Dual Diagn. 2017 Oct-Dec; 13(4):298-304. PMID: 29120266.
      Citations: 4     Fields:    Translation:Humans
    46. Simmons MM, Fincke BG, Drainoni ML, Kim B, Byrne T, Smelson D, Casey K, Ellison ML, Visher C, Blue-Howells J, McInnes DK. A two-state comparative implementation of peer-support intervention to link veterans to health-related services after incarceration: a study protocol. BMC Health Serv Res. 2017 Sep 12; 17(1):647. PMID: 28899394.
      Citations: 6     Fields:    Translation:Humans
    47. Trojano ML, Christopher PP, Pinals DA, Harnish A, Smelson D. Perceptions of voluntary consent among jail diverted veterans with co-occurring disorders. Behav Sci Law. 2017 Sep; 35(5-6):408-417. PMID: 28762534.
      Citations: 2     Fields:    Translation:Humans
    48. Blonigen DM, Rodriguez AL, Manfredi L, Nevedal A, Rosenthal J, McGuire JF, Smelson D, Timko C. Cognitive-behavioral treatments for criminogenic thinking: Barriers and facilitators to implementation within the Veterans Health Administration. Psychol Serv. 2018 Feb; 15(1):87-97. PMID: 28517949.
      Citations: 4     Fields:    Translation:Humans
    49. Simmons MM, Gabrielian S, Byrne T, McCullough MB, Smith JL, Taylor TJ, O'Toole TP, Kane V, Yakovchenko V, McInnes DK, Smelson DA. A Hybrid III stepped wedge cluster randomized trial testing an implementation strategy to facilitate the use of an evidence-based practice in VA Homeless Primary Care Treatment Programs. Implement Sci. 2017 04 04; 12(1):46. PMID: 28376839.
      Citations: 4     Fields:    Translation:Humans
    50. Chinman M, McCarthy S, Hannah G, Byrne TH, Smelson DA. Using Getting To Outcomes to facilitate the use of an evidence-based practice in VA homeless programs: a cluster-randomized trial of an implementation support strategy. Implement Sci. 2017 03 09; 12(1):34. PMID: 28279207.
      Citations: 7     Fields:    Translation:Humans
    51. Corrigan P, Schomerus G, Smelson D. Are some of the stigmas of addictions culturally sanctioned? Br J Psychiatry. 2017 03; 210(3):180-181. PMID: 28249945.
      Citations: 5     Fields:    Translation:Humans
    52. Finlay AK, Stimmel M, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I, Smelson D, Harris AH, Frayne SM, Bowe T, Timko C. Use of Veterans Health Administration Mental Health and Substance Use Disorder Treatment After Exiting Prison: The Health Care for Reentry Veterans Program. Adm Policy Ment Health. 2017 Mar; 44(2):177-187. PMID: 26687114.
      Citations: 16     Fields:    Translation:Humans
    53. Corrigan PW, Schomerus G, Shuman V, Kraus D, Perlick D, Harnish A, Kulesza M, Kane-Willis K, Qin S, Smelson D. Developing a research agenda for reducing the stigma of addictions, part II: Lessons from the mental health stigma literature. Am J Addict. 2017 Jan; 26(1):67-74. PMID: 27875626.
      Citations: 8     Fields:    Translation:Humans
    54. Corrigan P, Schomerus G, Shuman V, Kraus D, Perlick D, Harnish A, Kulesza M, Kane-Willis K, Qin S, Smelson D. Developing a research agenda for understanding the stigma of addictions Part I: Lessons from the Mental Health Stigma Literature. Am J Addict. 2017 Jan; 26(1):59-66. PMID: 27779803.
      Citations: 8     Fields:    Translation:Humans
    55. Harnish A, Corrigan P, Byrne T, Pinals DA, Rodrigues S, Smelson D. Substance Use and Mental Health Stigma in Veterans With Co-Occurring Disorders. J Dual Diagn. 2016 Jul-Dec; 12(3-4):238-243. PMID: 27723432.
      Citations: 2     Fields:    Translation:Humans
    56. Ellison ML, Schutt RK, Glickman ME, Schultz MR, Chinman M, Jensen K, Mitchell-Miland C, Smelson D, Eisen S. Patterns and predictors of engagement in peer support among homeless veterans with mental health conditions and substance use histories. Psychiatr Rehabil J. 2016 09; 39(3):266-273. PMID: 27618463.
      Citations: 5     Fields:    Translation:Humans
    57. Krebs P, Rogers E, Smelson D, Fu S, Wang B, Sherman S. Relationship between tobacco cessation and mental health outcomes in a tobacco cessation trial. J Health Psychol. 2018 07; 23(8):1119-1128. PMID: 27151069.
      Citations: 4     Fields:    Translation:Humans
    58. Smelson DA, Zaykowski H, Guevermont N, Siegfriedt J, Sawh L, Modzelewski D, Tsemberis S, Kane V. Integrating Permanent Supportive Housing and Co-Occurring Disorders Treatment for Individuals Who Are Homeless. J Dual Diagn. 2016 Apr-Jun; 12(2):193-201. PMID: 27064939.
      Citations: 14     Fields:    Translation:Humans
    59. Okunna NC, Rodriguez-Monguio R, Smelson DA, Poudel KC, Volberg R. Gambling involvement indicative of underlying behavioral and mental health disorders. Am J Addict. 2016 Mar; 25(2):160-72. PMID: 26871884.
      Citations: 4     Fields:    Translation:Humans
    60. Blonigen DM, Rodriguez AL, Manfredi L, Britt J, Nevedal A, Finlay AK, Rosenthal J, Smelson D, Timko C. The Availability and Utility of Services to Address Risk Factors for Recidivism among Justice-Involved Veterans. Crim Justice Policy Rev. 2017 10; 28(8):790-813. PMID: 26924887.
      Citations:    
    61. Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug Alcohol Depend. 2016 Mar 01; 160:222-6. PMID: 26832998.
      Citations: 17     Fields:    Translation:Humans
    62. Rogers ES, Smelson DA, Gillespie CC, Elbel B, Poole S, Hagedorn HJ, Kalman D, Krebs P, Fang Y, Wang B, Sherman SE. Telephone Smoking-Cessation Counseling for Smokers in Mental Health Clinics: A Patient-Randomized Controlled Trial. Am J Prev Med. 2016 Apr; 50(4):518-527. PMID: 26711163.
      Citations: 14     Fields:    Translation:Humans
    63. Carreiro S, Fang H, Zhang J, Wittbold K, Weng S, Mullins R, Smelson D, Boyer EW. iMStrong: Deployment of a Biosensor System to Detect Cocaine Use. J Med Syst. 2015 Dec; 39(12):186. PMID: 26490144.
      Citations: 25     Fields:    Translation:HumansPHPublic Health
    64. Gonzalez G, DiGirolamo G, Romero-Gonzalez M, Smelson D, Ziedonis D, Kolodziej M. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug Alcohol Depend. 2015 Nov 01; 156:243-253. PMID: 26454835.
      Citations: 6     Fields:    Translation:Humans
    65. McInnes DK, Fix GM, Solomon JL, Petrakis BA, Sawh L, Smelson DA. Preliminary needs assessment of mobile technology use for healthcare among homeless veterans. PeerJ. 2015; 3:e1096. PMID: 26246964.
      Citations:    
    66. Smelson DA, Chinman M, McCarthy S, Hannah G, Sawh L, Glickman M. A cluster randomized Hybrid Type III trial testing an implementation support strategy to facilitate the use of an evidence-based practice in VA homeless programs. Implement Sci. 2015 May 28; 10:79. PMID: 26018048.
      Citations: 6     Fields:    Translation:Humans
    67. DiGirolamo GJ, Smelson D, Guevremont N. Cue-induced craving in patients with cocaine use disorder predicts cognitive control deficits toward cocaine cues. Addict Behav. 2015 Aug; 47:86-90. PMID: 25900705.
      Citations: 7     Fields:    Translation:Humans
    68. Finlay AK, Binswanger IA, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, Timko C, Blodgett JC, Harris AH, Asch SM, Frayne S. Sex differences in mental health and substance use disorders and treatment entry among justice-involved Veterans in the Veterans Health Administration. Med Care. 2015 Apr; 53(4 Suppl 1):S105-11. PMID: 25767963.
      Citations: 9     Fields:    Translation:Humans
    69. Carreiro S, Smelson D, Ranney M, Horvath KJ, Picard RW, Boudreaux ED, Hayes R, Boyer EW. Real-time mobile detection of drug use with wearable biosensors: a pilot study. J Med Toxicol. 2015 Mar; 11(1):73-9. PMID: 25330747.
      Citations: 28     Fields:    Translation:HumansPHPublic Health
    70. McInnes DK, Sawh L, Petrakis BA, Rao S, Shimada SL, Eyrich-Garg KM, Gifford AL, Anaya HD, Smelson DA. The potential for health-related uses of mobile phones and internet with homeless veterans: results from a multisite survey. Telemed J E Health. 2014 Sep; 20(9):801-9. PMID: 25046280.
      Citations: 19     Fields:    Translation:Humans
    71. Finlay AK, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, Timko C, Binswanger I, Frayne SM, Blodgett JC, Bowe T, Clark SC, Harris AHS. U.S. Department of Veterans Affairs Veterans Justice Outreach Program: Connecting Justice-Involved Veterans with Mental Health and Substance Use Disorder Treatment. Crim Justice Policy Rev. 2016; 27(2). PMID: 32180665.
      Citations:    
    72. Rogers E, Fernandez S, Gillespie C, Smelson D, Hagedorn HJ, Elbel B, Kalman D, Axtmayer A, Kurowski K, Sherman SE. Telephone care coordination for smokers in VA mental health clinics: protocol for a hybrid type-2 effectiveness-implementation trial. Addict Sci Clin Pract. 2013 Mar 15; 8:7. PMID: 23497630.
      Citations: 9     Fields:    Translation:Humans
    73. Smelson DA, Kline A, Kuhn J, Rodrigues S, O'Connor K, Fisher W, Sawh L, Kane V. A wraparound treatment engagement intervention for homeless veterans with co-occurring disorders. Psychol Serv. 2013 May; 10(2):161-7. PMID: 23244030.
      Citations: 17     Fields:    Translation:Humans
    74. Smelson D, Yu L, Buyske S, Gonzalez G, Tischfield J, Deutsch CK, Ziedonis D. Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence. Am J Addict. 2012 Sep-Oct; 21(5):411-5. PMID: 22882391.
      Citations: 4     Fields:    Translation:HumansCells
    75. Smelson D, Chen KW, Ziedonis D, Andes K, Lennox A, Callahan L, Rodrigues S, Eisenberg D. A pilot study of Qigong for reducing cocaine craving early in recovery. J Altern Complement Med. 2013 Feb; 19(2):97-101. PMID: 22757968.
      Citations: 9     Fields:    Translation:Humans
    76. Ellison ML, Mueller L, Smelson D, Corrigan PW, Torres Stone RA, Bokhour BG, Najavits LM, Vessella JM, Drebing C. Supporting the education goals of post-9/11 veterans with self-reported PTSD symptoms: a needs assessment. Psychiatr Rehabil J. 2012; 35(3):209-17. PMID: 22246119.
      Citations: 8     Fields:    Translation:Humans
    77. Smelson D, Kalman D, Losonczy MF, Kline A, Sambamoorthi U, Hill LS, Castles-Fonseca K, Ziedonis D. A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community Ment Health J. 2012 Apr; 48(2):127-32. PMID: 20859765.
      Citations: 15     Fields:    Translation:Humans
    78. Boyer EW, Smelson D, Fletcher R, Ziedonis D, Picard RW. Wireless Technologies, Ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and Compliance with HIV Therapies. J Med Toxicol. 2010 Jun; 6(2):212-6. PMID: 20623215.
      Citations: 28     Fields:    Translation:Humans
    79. Kalman D, Kim S, DiGirolamo G, Smelson D, Ziedonis D. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clin Psychol Rev. 2010 Feb; 30(1):12-24. PMID: 19748166.
      Citations: 74     Fields:    Translation:Humans
    80. Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow FC. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull. 2011 Jul; 37(4):727-36. PMID: 19933540.
      Citations: 24     Fields:    Translation:Humans
    81. Banerjea R, Pogach LM, Smelson D, Sambamoorthi U. Mental illness and substance use disorders among women veterans with diabetes. Womens Health Issues. 2009 Nov-Dec; 19(6):446-56. PMID: 19879456.
      Citations: 8     Fields:    Translation:Humans
    82. Fortuna JL, Smelson DA. The phenomenon of drug craving. J Psychoactive Drugs. 2008 Sep; 40(3):255-61. PMID: 19004417.
      Citations: 1     Fields:    Translation:Humans
    83. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. J Behav Health Serv Res. 2008 Jul; 35(3):290-303. PMID: 18512155.
      Citations: 10     Fields:    Translation:Humans
    84. Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R. Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS Drugs. 2008; 22(11):903-16. PMID: 18840032.
      Citations: 6     Fields:    Translation:Humans
    85. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Chronic illness with complexities: mental illness and substance use among Veteran clinic users with diabetes. Am J Drug Alcohol Abuse. 2007; 33(6):807-21. PMID: 17994477.
      Citations: 15     Fields:    Translation:Humans
    86. Smelson DA, Tunis SL, Nyhuis AW, Faries DE, Kinon BJ, Ascher-Svanum H. Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use. J Clin Psychopharmacol. 2006 Dec; 26(6):666-7. PMID: 17110828.
      Citations: 5     Fields:    Translation:Humans
    87. Smelson DA, Ziedonis D, Williams J, Losonczy MF, Williams J, Steinberg ML, Kaune M. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clin Psychopharmacol. 2006 Feb; 26(1):9-12. PMID: 16415698.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    88. Sussner BD, Smelson DA, Rodrigues S, Kline A, Losonczy M, Ziedonis D. The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend. 2006 Jul 27; 83(3):233-7. PMID: 16384655.
      Citations: 63     Fields:    Translation:Humans
    89. Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract. 2005 Sep; 11(5):315-39. PMID: 16184072.
      Citations: 48     Fields:    Translation:Humans
    90. Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat. 2004 Jul; 27(1):45-9. PMID: 15223093.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    91. Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA. 2003 Nov 26; 290(20):2693-702. PMID: 14645311.
      Citations: 74     Fields:    Translation:HumansCTClinical Trials
    92. Ziedonis D, Williams JM, Smelson D. Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am J Med Sci. 2003 Oct; 326(4):223-30. PMID: 14557739.
      Citations: 34     Fields:    Translation:Humans
    93. Smelson DA, Davis CW, Eisenstein N, Engelhart C, Williams J, Losonczy MF, Ziedonis D. Cognitive disparity in schizophrenics with and without cocaine dependency. J Subst Abuse Treat. 2003 Jan; 24(1):75-9. PMID: 12646333.
      Citations: 3     Fields:    Translation:Humans
    94. Smelson DA, Losonczy MF, Kilker C, Starosta A, Kind J, Williams J, Ziedonis D. An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine. Psychiatr Serv. 2002 Dec; 53(12):1612-6. PMID: 12461224.
      Citations: 8     Fields:    Translation:Humans
    95. Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry. 2002 Sep; 47(7):671-5. PMID: 12355680.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    96. Smelson DA, Davis CW, Di Pano R, Johnson V, Losonczy MF, Ziedonis D. Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics. J Nerv Ment Dis. 2002 Mar; 190(3):200-2. PMID: 11923656.
      Citations: 4     Fields:    Translation:Humans
    97. Carol G, Smelson DA, Losonczy MF, Ziedonis D. Alcohol & drug abuse: a preliminary investigation of cocaine craving among persons with and without schizophrenia. Psychiatr Serv. 2001 Aug; 52(8):1029-31. PMID: 11474045.
      Citations: 2     Fields:    Translation:Humans
    98. Smelson DA, Roy A, Roy M, Tershakovec D, Engelhart C, Losonczy MF. Electroretinogram and cue-elicited craving in withdrawn cocaine-dependent patients: a replication. Am J Drug Alcohol Abuse. 2001 May; 27(2):391-7. PMID: 11417946.
      Citations: 5     Fields:    Translation:Humans
    99. Smelson DA, Roy A, Santana S, Engelhart C. Neuropsychological deficits in withdrawn cocaine-dependent males. Am J Drug Alcohol Abuse. 1999 May; 25(2):377-81. PMID: 10395167.
      Citations: 6     Fields:    Translation:Humans
    100. Smelson DA, McGee-Caulfield E, Bergstein P, Engelhart C. Initial validation of the Voris Cocaine Craving Scale: a preliminary report. J Clin Psychol. 1999 Jan; 55(1):135-9. PMID: 10100840.
      Citations: 1     Fields:    Translation:Humans
    101. Howanitz E, Pardo M, Smelson DA, Engelhart C, Eisenstein N, Stern RG, Losonczy MF. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. J Clin Psychiatry. 1999 Jan; 60(1):41-4. PMID: 10074877.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    102. Roy A, Roy M, Smelson DA. Risperidone, ERG and cocaine craving. Am J Addict. 1998; 7(1):90. PMID: 9522012.
      Citations: 2     Fields:    Translation:Humans
    103. Smelson DA, Roy A, Roy M. Risperidone diminishes cue-elicited craving in withdrawn cocaine-dependent patients. Can J Psychiatry. 1997 Nov; 42(9):984. PMID: 9429074.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    104. Roy M, Roy A, Smelson D, Brown S, Weinberger L. Reduced blue cone electroretinogram in withdrawn cocaine dependent patients: a replication. Biol Psychiatry. 1997 Oct 01; 42(7):631-3. PMID: 9376460.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    105. Smelson DA, Kordon ME, Rudolph B. Evaluating the diagnostic interview: obstacles and future directions. J Clin Psychol. 1997 Aug; 53(5):497-505. PMID: 9257229.
      Citations:    Fields:    Translation:Humans
    106. Desai P, Roy M, Roy A, Brown S, Smelson D. Impaired color vision in cocaine-withdrawn patients. Arch Gen Psychiatry. 1997 Aug; 54(8):696-9. PMID: 9283503.
      Citations: 7     Fields:    Translation:Humans
    107. Roy M, Roy A, Williams J, Weinberger L, Smelson D. Reduced blue cone electroretinogram in cocaine-withdrawn patients. Arch Gen Psychiatry. 1997 Feb; 54(2):153-6. PMID: 9040283.
      Citations: 2     Fields:    Translation:HumansCells
    108. Roy M, Smelson D, Roy A. Longitudinal study of blue cone retinal function in cocaine-withdrawn patients. Biol Psychiatry. 1997 Jan 15; 41(2):252-3. PMID: 9018402.
      Citations:    Fields:    Translation:HumansCells
    109. Roy A, Smelson D, Lindeken S. Screening for pathological gambling among substance misusers. Br J Psychiatry. 1996 Oct; 169(4):523. PMID: 8894208.
      Citations:    Fields:    Translation:HumansPHPublic Health
    110. Smelson DA, Roy A, Roy M. The electroretinogram and neuropsychological functioning in cocaine addicts. Can J Psychiatry. 1996 Aug; 41(6):415. PMID: 8862864.
      Citations:    Fields:    Translation:Humans
    111. Roy M, Smelson DA, Roy A. Abnormal electroretinogram in cocaine-dependent patients. Relationship to craving. Br J Psychiatry. 1996 Apr; 168(4):507-11. PMID: 8730949.
      Citations: 3     Fields:    Translation:HumansCells
    112. Smelson DA. Adolescent substance abuse prevention. N J Med. 1993 Nov; 90(11):845-8. PMID: 8272276.
      Citations:    Fields:    Translation:HumansPHPublic Health
    Smelson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (308)
    Explore
    _
    Co-Authors (24)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _